Methotrexate Induced Oral Mucositis and Bone Marrow Suppression in Psoriatic Patient
Aadithya, Raghuveer S Prabhu & Rahmathullah SN · International Journal of Medical and Pharmaceutical Case Reports · 2024
Methotrexate is an antimetabolite which binds to the dihydrofolate reductase enzyme and used in the treatment of malignant disorders and autoimmune diseases. Myelosuppression is a serious complication of methotrexate toxicity. The following case describes a case of 67 year old ma...
Open access
Research Article
10.9734/ijmpcr/2024/v17i2381